The Medipattern Corporation
TSX VENTURE : MKI

The Medipattern Corporation

July 31, 2012 08:08 ET

Medipattern mHealth Begins Shipments to Target

SMARTCOACH slated to be available in stores this fall

TORONTO, ONTARIO--(Marketwire - July 31, 2012) -

Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a healthcare leader in the development and commercialization of prevention and analysis solutions that positively impact people's lives, announced today that its MyTrak Mobile unit has received a lead order from Target Corporation (Target) for immediate delivery of SMARTCOACH™, mobile coaching and engagement device. Target intends to roll out SMARTCOACH in the United States this Fall. Discussions leading to this order took place between Target and MyTrak Health System's M2 Division which subsequently became Medipattern's mHealth Solutions Business Unit. The lead order will supply Target's 25 distribution centers across the United States.

SMARTCOACH is a wearable mobile health device supported with online management and coach advisors that help its customers make the lifestyle changes that positively impact their health and well being. SMARTCOACH is with each customer through every step they take, monitoring progress and encouraging success. SMARTCOACH further supplies analysis tools to understand which activities and behaviors have the most significant impact and continues to support each customer through the online community. Unlike pedometer based technologies, SMARTCOACH is a small, sophisticated computer that uses patented Smart Body Technology™ to sense, analyze, and track body movements in 3-D. SMARTCOACH ties in to each customer's computer, using advanced interactive graphics to manage lifestyle changes. Each customer can see the steps taken, distance traveled, and energy expended to optimize heart activity and metabolism.

"We are very pleased to add Target to our retail network," commented Jeff Collins, CEO of Medipattern. "SMARTCOACH offers a very unique user experience that coaches and engages individuals to achieve personalized goals. It is not just about how many steps you have taken but rather where those steps are taking you."

About the Medipattern Corporation:

Medipattern® is a healthcare leader in the development and commercialization of prevention and analysis solutions that positively impact people's lives through Medipattern's Knowledge-based Informatics (MKI). Medipattern mHealth uses patented prevention technologies to engage, coach and monitor people in achieving their personalized goals. Medipattern iaHealth uses patented pattern recognition technology to analyze medical data to aid medical practitioners in the assessment of disease and critical anatomy. For more information, please visit the Company's website: www.medipattern.com.

Medipattern® is a registered trademark of The Medipattern Corporation. MyTrak® is a registered trademark and SMARTCOACH is a trademark of MYTRAK Health Systems and will be under temporary license to Medipattern while the company reviews branding.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). These factors should be considered carefully, and readers should not place undue reliance on Medipattern's forward-looking statements. In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information